NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
about
Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experienceNatural killer cells promote early CD8 T cell responses against cytomegalovirusMolecular mechanisms of Ebola virus pathogenesis: focus on cell death.Evasion of natural killer cells by influenza virus.The structural basis of ligand recognition by natural killer cell receptors.Evasion of the interferon-mediated antiviral response by filoviruses.Filovirus vaccines.Structural insights into activation of antiviral NK cell responsesRoles of natural killer cells in antiviral immunityAnalysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohortUmbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.Protection against filovirus infection: virus-like particle vaccines.Here today--not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections.Natural killer cells in immunodefense against infective agents.Structural basis for recognition of cellular and viral ligands by NK cell receptors.Correlates of immunity to filovirus infection.Virus-mediated inhibition of natural cytotoxicity receptor recognition.TLR/NCR/KIR: Which One to Use and When?Animal models for ebolavirus countermeasures discovery: what defines a useful model?Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon.Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression.Nonhuman primates as models for the discovery and development of ebolavirus therapeutics.Vaccinating for natural killer cell effector functions.Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.Utility of Mouse Models in Vaccine Design and Development
P2860
Q26850968-7E3273DD-D887-4691-B110-EA9C70AD01F3Q27319836-10C2F72E-D379-4EE6-826F-6A23FCBE6697Q34478514-F3086F02-5904-426E-9919-92E5250A35E5Q34510128-F5700301-2E7F-4A94-90DD-ACA127E684D8Q35001148-AB6CDB80-F45D-4F54-BD64-1541DDDD7667Q35260239-9450138F-E487-4082-85DA-3CEE6FA34446Q35558539-B3322E13-11C8-4CE9-81CE-8E5D7E548292Q36317668-B79A46EA-11EA-417B-B100-666E3E089C78Q36767761-6FFCD580-D2FC-4317-8F01-9D6AA0DBDA68Q36866176-3A8533FA-7E63-478D-AD71-B9A42E6FD8EBQ37039243-4C42C290-3BE8-452D-8120-8D98EEBB5CE4Q37130463-41BF86F1-C2A5-4D27-841B-239D859244A5Q37148437-CAC57EF3-C77B-4844-8F9B-EFD2C0365F90Q37178929-E6EC960A-931F-4577-B1F2-DCE089611F6DQ37678862-A5BFBA42-825F-4F36-97A6-1BADABF6275EQ37945233-7BFFF406-A0C2-49FD-89CB-22CF2DF2B8F6Q38006620-524E18A1-FF9F-4669-B140-FEFACD23FFD3Q38200088-695C44B3-8FF2-47BB-AD83-4F453A23B30AQ38500788-2ACBF7F7-3B76-41FC-BE16-E830D5AF8678Q38886708-0E3878BC-D1E5-4AEC-9825-08D90E5AAB75Q39399591-F66CFA1A-7323-442C-8279-7E88C6D97829Q39546314-CDCFA8BA-461F-4FC5-8544-64678526C46EQ40145714-AF946107-46A2-4B22-B838-719CAD031130Q40287006-BB97F4DE-0519-47BD-B50E-6A22C560413FQ40332893-4B06643F-5A5E-4855-AD9A-A1B1A20E69B1Q50301007-CAC61BF7-B90E-4912-80DD-B4410811DEDDQ51784219-2278B1B9-C743-46B2-B1E4-2644DC33124CQ56921950-736C95AB-5750-4D1C-87B7-E77B02FC693A
P2860
NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
@en
type
label
NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
@en
prefLabel
NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
@en
P2093
P2860
P1476
NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
@en
P2093
Catharine M Bosio
Claudette L Fuller
Dana L Swenson
Gordon Ruthel
Kelly L Warfield
M Javad Aman
P2860
P304
P356
10.1111/J.1462-5822.2006.00844.X
P50
P577
2007-04-01T00:00:00Z